-
1
-
-
0037072064
-
Alzheimer's disease
-
DOI 10.1016/S0140-6736(02)09420-5
-
Burns A., Byrne E. J., Maurer K., Alzheimer's disease The Lancet 2002 360 9327 163 165 (Pubitemid 34786210)
-
(2002)
Lancet
, vol.360
, Issue.9327
, pp. 163-165
-
-
Burns, A.1
Byrne, E.J.2
Maurer, K.3
-
2
-
-
0024317904
-
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
-
Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O., Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported Journal of the American Medical Association 1989 262 18 2551 2556
-
(1989)
Journal of the American Medical Association
, vol.262
, Issue.18
, pp. 2551-2556
-
-
Evans, D.A.1
Funkenstein, H.H.2
Albert, M.S.3
Scherr, P.A.4
Cook, N.R.5
Chown, M.J.6
Hebert, L.E.7
Hennekens, C.H.8
Taylor, J.O.9
-
3
-
-
0042023711
-
Alzheimer disease in the US population: Prevalence estimates using the 2000 census
-
DOI 10.1001/archneur.60.8.1119
-
Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., Evans D. A., Alzheimer disease in the US population: prevalence estimates using the 2000 census Archives of Neurology 2003 60 8 1119 1122 (Pubitemid 36975801)
-
(2003)
Archives of Neurology
, vol.60
, Issue.8
, pp. 1119-1122
-
-
Hebert, L.E.1
Scherr, P.A.2
Bienias, J.L.3
Bennett, D.A.4
Evans, D.A.5
-
4
-
-
2942561028
-
The importance of neuritic plaques and tangles to the development and evolution of AD
-
Tiraboschi P., Hansen L. A., Thal L. J., Corey-Bloom J., The importance of neuritic plaques and tangles to the development and evolution of AD Neurology 2004 62 11 1984 1989 (Pubitemid 38738208)
-
(2004)
Neurology
, vol.62
, Issue.11
, pp. 1984-1989
-
-
Tiraboschi, P.1
Hansen, L.A.2
Thal, L.J.3
Corey-Bloom, J.4
-
5
-
-
0042508791
-
Neuropathologic changes in Alzheimer's disease
-
Wenk G. L., Neuropathologic changes in Alzheimer's disease Journal of Clinical Psychiatry 2003 64 9 7 10 (Pubitemid 37040372)
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.SUPPL. 9
, pp. 7-10
-
-
Wenk, G.L.1
-
6
-
-
12144288683
-
Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease
-
Schmitz C., Rutten B. P. F., Pielen A., Schfer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H. W. M., Pradier L., Bayer T. A., Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease American Journal of Pathology 2004 164 4 1495 1502 (Pubitemid 38387814)
-
(2004)
American Journal of Pathology
, vol.164
, Issue.4
, pp. 1495-1502
-
-
Schmitz, C.1
Rutten, B.P.F.2
Pielen, A.3
Schafer, S.4
Wirths, O.5
Tremp, G.6
Czech, C.7
Blanchard, V.8
Multhaup, G.9
Rezaie, P.10
Korr, H.11
Steinbusch, H.W.M.12
Pradier, L.13
Bayer, T.A.14
-
7
-
-
47149112621
-
42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial
-
DOI 10.1016/S0140-6736(08)61075-2, PII S0140673608610752
-
Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R. W., Bullock R., Love S., Neal J. W., Zotova E., Nicoll J. A., Long-term effects of A 42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial The Lancet 2008 372 9634 216 223 (Pubitemid 351978111)
-
(2008)
The Lancet
, vol.372
, Issue.9634
, pp. 216-223
-
-
Holmes, C.1
Boche, D.2
Wilkinson, D.3
Yadegarfar, G.4
Hopkins, V.5
Bayer, A.6
Jones, R.W.7
Bullock, R.8
Love, S.9
Neal, J.W.10
Zotova, E.11
Nicoll, J.A.12
-
8
-
-
0032910197
-
The cholinergic hypothesis of Alzheimer's disease: A review of progress
-
Francis P. T., Palmer A. M., Snape M., Wilcock G. K., The cholinergic hypothesis of Alzheimer's disease: a review of progress Journal of Neurology Neurosurgery and Psychiatry 1999 66 2 137 147 (Pubitemid 29103513)
-
(1999)
Journal of Neurology Neurosurgery and Psychiatry
, vol.66
, Issue.2
, pp. 137-147
-
-
Francis, P.T.1
Palmer, A.M.2
Snape, M.3
Wilcock, G.K.4
-
9
-
-
4143052423
-
Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial
-
Salloway S., Ferris S., Kluger A., Goldman R., Griesing T., Kumar D., Richardson S., Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial Neurology 2004 63 4 651 657 (Pubitemid 39100820)
-
(2004)
Neurology
, vol.63
, Issue.4
, pp. 651-657
-
-
Salloway, S.1
Ferris, S.2
Kluger, A.3
Goldman, R.4
Griesing, T.5
Kumar, D.6
Richardson, S.7
-
11
-
-
33845384117
-
The use of herbal medicine in Alzheimer's disease - A systematic review
-
DOI 10.1093/ecam/nel071
-
Santos-Neto L. L. D., de Vilhena Toledo M. A., Medeiros-Souza P., De Souza G. A., The use of herbal medicine in Alzheimer's diseasea systematic review Evidence-Based Complementary and Alternative Medicine 2006 3 4 441 445 (Pubitemid 44899981)
-
(2006)
Evidence-based Complementary and Alternative Medicine
, vol.3
, Issue.4
, pp. 441-445
-
-
Santos-Neto, L.L.D.1
De Vilhena Toledo, M.A.2
Medeiros-Souza, P.3
De Souza, G.A.4
-
12
-
-
47849090239
-
Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease
-
Man S. C., Durairajan S. S. K., Kum W. F., Lu J. H., Huang J. D., Cheng C. F., Chung V., Xu M., Li M., Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease Journal of Alzheimer's Disease 2008 14 2 209 223 (Pubitemid 352040038)
-
(2008)
Journal of Alzheimer's Disease
, vol.14
, Issue.2
, pp. 209-223
-
-
Man, S.C.1
Durairajan, S.S.K.2
Kum, W.F.3
Lu, J.H.4
Huang, J.D.5
Cheng, C.F.6
Chung, V.7
Xu, M.8
Li, M.9
-
13
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
-
DOI 10.1016/0197-2456(95)00134-4
-
Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J. M., Gavaghan D. J., McQuay H. J., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1 1 12 (Pubitemid 26120810)
-
(1996)
Controlled Clinical Trials
, vol.17
, Issue.1
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, D.J.M.5
Gavaghan, D.J.6
McQuay, H.J.7
-
14
-
-
0030775196
-
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type
-
DOI 10.1016/S0022-3956(97)00022-8, PII S0022395697000228
-
Maurer K., Ihl R., Dierks T., Frlich L., Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type Journal of Psychiatric Research 1997 31 6 645 655 (Pubitemid 27522447)
-
(1997)
Journal of Psychiatric Research
, vol.31
, Issue.6
, pp. 645-655
-
-
Maurer, K.1
Ihl, R.2
Dierks, T.3
Frolich, L.4
-
15
-
-
28244446721
-
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type
-
Schneider L. S., DeKosky S. T., Farlow M. R., Tariot P. N., Hoerr R., Kieser M., A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type Current Alzheimer Research 2005 2 5 541 551 (Pubitemid 41703672)
-
(2005)
Current Alzheimer Research
, vol.2
, Issue.5
, pp. 541-551
-
-
Schneider, L.S.1
DeKosky, S.T.2
Farlow, M.R.3
Tariot, P.N.4
Hoerr, R.5
Kieser, M.6
-
16
-
-
33747823312
-
Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study
-
DOI 10.1111/j.1468-1331.2006.01409.x
-
Mazza M., Capuano A., Bria P., Mazza S., Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study European Journal of Neurology 2006 13 9 981 985 (Pubitemid 44284905)
-
(2006)
European Journal of Neurology
, vol.13
, Issue.9
, pp. 981-985
-
-
Mazza, M.1
Capuano, A.2
Bria, P.3
Mazza, S.4
-
17
-
-
0029112606
-
Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease
-
Xu S.-S., Gao Z.-X., Weng Z., Du Z.-M., Xu W.-A., Yang J.-S., Zhang M.-L., Tong Z.-H., Fang Y.-S., Chai X.-S., Li S.-L., Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease Acta Pharmacologica Sinica 1995 16 5 391 395
-
(1995)
Acta Pharmacologica Sinica
, vol.16
, Issue.5
, pp. 391-395
-
-
Xu, S.-S.1
Gao, Z.-X.2
Weng, Z.3
Du, Z.-M.4
Xu, W.-A.5
Yang, J.-S.6
Zhang, M.-L.7
Tong, Z.-H.8
Fang, Y.-S.9
Chai, X.-S.10
Li, S.-L.11
-
18
-
-
0037173785
-
Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial
-
Zhang Z., Wang X., Chen Q., Shu L., Wang J., Shan G., Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial Zhonghua yi xue za zhi 2002 82 14 941 944
-
(2002)
Zhonghua Yi Xue Za Zhi
, vol.82
, Issue.14
, pp. 941-944
-
-
Zhang, Z.1
Wang, X.2
Chen, Q.3
Shu, L.4
Wang, J.5
Shan, G.6
-
19
-
-
54549111180
-
An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease
-
Heo J.-H., Lee S.-T., Chu K., Oh M. J., Park H.-J., Shim J.-Y., Kim M., An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease European Journal of Neurology 2008 15 8 865 868
-
(2008)
European Journal of Neurology
, vol.15
, Issue.8
, pp. 865-868
-
-
Heo, J.-H.1
Lee, S.-T.2
Chu, K.3
Oh, M.J.4
Park, H.-J.5
Shim, J.-Y.6
Kim, M.7
-
20
-
-
34347370406
-
Ginkgo biloba extract (EGb 761) in Alzheimer's disease: Is there any evidence?
-
DOI 10.2174/156720507781077304
-
Ramassamy C., Longpr F., Christen Y., Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence? Current Alzheimer Research 2007 4 3 253 262 (Pubitemid 47025423)
-
(2007)
Current Alzheimer Research
, vol.4
, Issue.3
, pp. 253-262
-
-
Ramassamy, C.1
Longpre, F.2
Christen, Y.3
-
21
-
-
20944446415
-
Neuroprotective effects of huperzine A: A natural cholinesterase inhibitor for the treatment of Alzheimer's disease
-
DOI 10.1159/000085387
-
Wang R., Xi C. T., Neuroprotective effects of huperzine A: a natural cholinesterase inhibitor for the treatment of Alzheimer's disease NeuroSignals 2005 14 1-2 71 82 (Pubitemid 40868985)
-
(2005)
NeuroSignals
, vol.14
, Issue.1-2
, pp. 71-82
-
-
Wang, R.1
Xi, C.T.2
-
22
-
-
33750943629
-
Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease
-
DOI 10.1016/j.tips.2006.10.004, PII S0165614706002471
-
Zhang H. Y., Tang X. C., Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease Trends in Pharmacological Sciences 2006 27 12 619 625 (Pubitemid 44738090)
-
(2006)
Trends in Pharmacological Sciences
, vol.27
, Issue.12
, pp. 619-625
-
-
Zhang, H.Y.1
Tang, X.C.2
-
23
-
-
33746435758
-
Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β-amyloid proteins
-
DOI 10.1002/jnr.20891
-
Fujiwara H., Iwasaki K., Furukawa K., Seki T., He M., Maruyama M., Tomita N., Kudo Y., Higuchi M., Saido T. C., Maeda S., Takashima A., Hara M., Ohizumi Y., Arai H., Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's -amyloid proteins Journal of Neuroscience Research 2006 84 2 427 433 (Pubitemid 44126295)
-
(2006)
Journal of Neuroscience Research
, vol.84
, Issue.2
, pp. 427-433
-
-
Fujiwara, H.1
Iwasaki, K.2
Furukawa, K.3
Seki, T.4
He, M.5
Maruyama, M.6
Tomita, N.7
Kudo, Y.8
Higuchi, M.9
Saido, T.C.10
Maeda, S.11
Takashima, A.12
Hara, M.13
Ohizumi, Y.14
Arai, H.15
-
24
-
-
4043151473
-
Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid β-protein in cultured cells
-
DOI 10.1016/j.neulet.2004.05.093, PII S0304394004006913
-
Jia H., Jiang Y., Ruan Y., Zhang Y., Ma X., Zhang J., Beyreuther K., Tu P., Zhang D., Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid -protein in cultured cells Neuroscience Letters 2004 367 1 123 128 (Pubitemid 39078799)
-
(2004)
Neuroscience Letters
, vol.367
, Issue.1
, pp. 123-128
-
-
Jia, H.1
Jiang, Y.2
Ruan, Y.3
Zhang, Y.4
Ma, X.5
Zhang, J.6
Beyreuther, K.7
Tu, P.8
Zhang, D.9
-
25
-
-
16644385507
-
Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa
-
Kim D. K., Lee K. T., Baek N. I., Kim S. H., Park H. W., Lim J. P., Shin T. Y., Eom D. O., Yang J. H., Eun J. S., Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa Archives of Pharmacal Research 2004 27 11 1127 1131
-
(2004)
Archives of Pharmacal Research
, vol.27
, Issue.11
, pp. 1127-1131
-
-
Kim, D.K.1
Lee, K.T.2
Baek, N.I.3
Kim, S.H.4
Park, H.W.5
Lim, J.P.6
Shin, T.Y.7
Eom, D.O.8
Yang, J.H.9
Eun, J.S.10
-
26
-
-
33751509301
-
Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Aβ secretion
-
DOI 10.1016/j.bbrc.2006.11.043, PII S0006291X06025150
-
Asai M., Iwata N., Yoshikawa A., Aizaki Y., Ishiura S., Saido T. C., Maruyama K., Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease A secretion Biochemical and Biophysical Research Communications 2007 352 2 498 502 (Pubitemid 44838513)
-
(2007)
Biochemical and Biophysical Research Communications
, vol.352
, Issue.2
, pp. 498-502
-
-
Asai, M.1
Iwata, N.2
Yoshikawa, A.3
Aizaki, Y.4
Ishiura, S.5
Saido, T.C.6
Maruyama, K.7
-
27
-
-
0035808457
-
Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
-
DOI 10.1074/jbc.M002466200
-
Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J. A., Snyder G. L., Greengard P., Biernat J., Wu Y.-Z., Mandelkow E.-M., Eisenbrand G., Meijert L., Indirubins inhibit glycogen synthase kinase-3 and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? Journal of Biological Chemistry 2001 276 1 251 260 (Pubitemid 32050314)
-
(2001)
Journal of Biological Chemistry
, vol.276
, Issue.1
, pp. 251-260
-
-
Leclerc, S.1
Garnier, M.2
Hoessel, R.3
Marko, D.4
Bibb, J.A.5
Snyder, G.L.6
Greengard, P.7
Biernat, J.8
Wu, Y.-Z.9
Mandelkow, E.-M.10
Eisenbrand, G.11
Meijert, L.12
-
28
-
-
33845672995
-
Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides
-
Chen F., Eckman E. A., Eckman C. B., Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides The FASEB Journal 2006 20 8 1269 1271
-
(2006)
The FASEB Journal
, vol.20
, Issue.8
, pp. 1269-1271
-
-
Chen, F.1
Eckman, E.A.2
Eckman, C.B.3
-
29
-
-
44949217683
-
Huperzine A for Alzheimer's disease
-
Li J., Wu H. M., Zhou R. L., Liu G. J., Dong B. R., Huperzine A for Alzheimer's disease Cochrane Database of Systematic Reviews 2008 2
-
(2008)
Cochrane Database of Systematic Reviews
, Issue.2
-
-
Li, J.1
Wu, H.M.2
Zhou, R.L.3
Liu, G.J.4
Dong, B.R.5
-
30
-
-
0034572281
-
ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)validation of the Slovak version
-
Kolibas E., Korinkova V., Novotny V., Vajdickova K., Hunakova D., ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)validation of the Slovak version Bratislavske Lekarske Listy 2000 101 11 598 602
-
(2000)
Bratislavske Lekarske Listy
, vol.101
, Issue.11
, pp. 598-602
-
-
Kolibas, E.1
Korinkova, V.2
Novotny, V.3
Vajdickova, K.4
Hunakova, D.5
-
31
-
-
34247590127
-
Alzheimer's disease drug discovery from herbs: Neuroprotectivity from β-amyloid (1-42) insult
-
DOI 10.1089/acm.2006.6107
-
Kim D. S. H. L., Kim J.-Y., Han Y. S., Alzheimer's disease drug discovery from herbs: neuroprotectivity from -amyloid (1-42) insult Journal of Alternative and Complementary Medicine 2007 13 3 333 340 (Pubitemid 46676776)
-
(2007)
Journal of Alternative and Complementary Medicine
, vol.13
, Issue.3
, pp. 333-340
-
-
Kim, D.S.H.L.1
Kim, J.-Y.2
Han, Y.S.3
|